Animate Biosciences

Animate Biosciences is an early-stage biotech (founded 2021) pioneering an AI-powered platform for regenerative peptide therapeutics. The company targets pathological tissue remodeling, a process implicated in nearly half of global deaths, across multiple organ systems including pulmonary, dermatology, cardiac, and hepatic. By combining multi-omic data from regenerative organisms with generative AI, Animate aims to rapidly design and develop scalable therapeutics for conditions with limited treatment options. Its leadership team brings together expertise in regenerative biology, machine learning, and biotech entrepreneurship.

Proprietary AI-powered platform that uses multi-omic data from nature's super-regenerators (e.g., certain salamanders, zebrafish) to design novel peptide therapeutics targeting pathological tissue remodeling.

Competes in the broad and competitive fields of anti-fibrotics and regenerative medicine, facing large pharma and biotechs using modalities like small molecules, antibodies, and cell therapies. Its unique differentiation is the combination of insights from super-regenerators with generative AI for peptide design, a novel approach not widely employed.